Cost-effectiveness of implementing a digital psychosocial intervention for patients with psychotic spectrum disorders in low- and middle-income countries in Southeast Europe: economic evaluation alongside a cluster randomised trial
Open Access
- 26 August 2022
- journal article
- research article
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 65 (1) , 1-29
Abstract
Background DIALOG+ is a digital psychosocial intervention aimed at making routine meetings between patients and clinicians therapeutically effective. This study aimed to evaluate the cost-effectiveness of implementing DIALOG+ treatment for patients with psychotic disorders in five low- and middle-income countries in Southeast Europe alongside a cluster randomised trial. Methods Resource use and quality of life data were collected alongside the multi-country cluster randomised trial of 468 participants with psychotic disorders. Due to COVID-19 interruptions of the trial's original 12-month intervention period, adjusted costs and quality-adjusted life years (QALYs) were estimated at the participant level using a mixed-effects model over the first 6 months only. We estimated the incremental cost-effectiveness ratio (ICER) with uncertainty presented using a cost-effectiveness plane and a cost-effectiveness acceptability curve. Seven sensitivity analyses were conducted to check the robustness of the findings. Results The average cost of delivering DIALOG+ was euro91.11 per participant. DIALOG+ was associated with an incremental health gain of 0.0032 QALYs (95% CI -0.0015, 0.0079), incremental costs of euro84.17 (95% CI -8.18, 176.52), and an estimated ICER of euro26,347.61. The probability of DIALOG+ being cost-effective against three times the weighted gross domestic product (GDP) per capita for the five participating countries was 18.9%. Conclusion Evidence from the cost-effectiveness analyses in this study suggested that DIALOG+ involved relatively low costs. However, it is not likely to be cost-effective in the five participating countries compared with standard care against a willingness-to-pay threshold of three times the weighted GDP per capita per QALY gained.Keywords
This publication has 29 references indexed in Scilit:
- Exploring the Mechanisms of a Patient-Centred Assessment with a Solution Focused Approach (DIALOG+) in the Community Treatment of Patients with Psychosis: A Process Evaluation within a Cluster-Randomised Controlled TrialPLOS ONE, 2016
- The Effectiveness of a Patient-Centred Assessment with a Solution-Focused Approach (DIALOG+) for Patients with Psychosis: A Pragmatic Cluster-Randomised Controlled Trial in Community CarePsychotherapy and Psychosomatics, 2015
- Economic Evaluation alongside Multinational Studies: A Systematic Review of Empirical StudiesPLOS ONE, 2015
- Developing Appropriate Methods for Cost-Effectiveness Analysis of Cluster Randomized TrialsMedical Decision Making, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Is the EQ–5D fit for purpose in mental health?The British Journal of Psychiatry, 2010
- Non-uniform effectiveness of structured patient–clinician communication in community mental healthcare: an international comparisonSocial Psychiatry and Psychiatric Epidemiology, 2010
- The therapeutic relationship in psychiatric settingsActa Psychiatrica Scandinavica, 2006
- Conducting economic evaluations alongside multinational clinical trials: Toward a research consensusAmerican Heart Journal, 2005
- Analysis of serial measurements in medical research.BMJ, 1990